Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Virginia L, Mihalick"'
Publikováno v:
European Journal of Applied Physiology. 123:975-988
Autor:
Anson M. Blanks, Thomas T. Wagamon, Lindsay Lafratta, Mabel G. Sisk, Morgan B. Senter, Lauren N. Pedersen, Natalie Bohmke, Attiya Shah, Virginia L. Mihalick, R. Lee Franco
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 2, Iss , Pp 100033- (2020)
Coronary artery disease (CAD) is an immune-mediated disease in which CCR2 attracts classical, intermediate, and non-classical monocytes to the arterial intima where they differentiate to macrophages. Balance between pro-inflammatory M1 and anti-infla
Externí odkaz:
https://doaj.org/article/1eb46f0b8e9e4ccd854fd3eb19772333
Autor:
Ross Arena, Juan Ignacio Damonte, Roshanak Markley, Hayley Billingsley, Azita Hajhossein Talasaz, Emily Federmann, Antonio Abbate, Benjamin W. Van Tassell, Salvatore Carbone, Justin M. Canada, Cory R. Trankle, Juan Lu, Ai-Chen Ho, Alessandra Vecchié, Virginia L. Mihalick, Jeremy Turlington, Marco Giuseppe Del Buono, George F. Wohlford, Dinesh Kadayira
Publikováno v:
Am J Cardiol
There is limited understanding on the potential differences in the pathophysiology between de novo heart failure with reduced ejection fraction (HFrEF) and acute on chronic HFrEF. The aim of this study was to assess differences in cardiorespiratory f
Publikováno v:
Progress in Cardiovascular Diseases
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has presented a global public health emergency. Although predominantly a pandemic of acute respiratory disease, corona virus infectious disease-19 (COVID
Publikováno v:
European journal of applied physiology.
Elevated low-density lipoprotein (LDL) and triglyceride concentrations are associated with future cardiovascular risk in young adults. Conversely, chronic physical activity is generally accepted to reduce CVD risk. Atherosclerosis is a major underlyi
Autor:
Anson M. Blanks, Lauren N. Pedersen, Heather L. Caslin, Virginia L. Mihalick, Jeremy Via, Justin M. Canada, Benjamin Van Tassell, Salvatore Carbone, Antonio Abbate, R. Lee Franco
Publikováno v:
Diabetes Research and Clinical Practice. 191:110077
Following ST-segment elevation myocardial infarction (STEMI), recruitment and activation of monocytes [classical (CD14Post-STEMI subjects were identified as normal random glucose (NG,98 mg/dL, n = 13) or impaired random glucose (IG, ≥98 mg/dL, n =
Autor:
Antonio Abbate, Dinesh Kadariya, George F. Wohlford, Dana Austin, Juan Guido Chiabrando, Benjamin W. Van Tassell, Cohava Gelber, Leo F. Buckley, Taeshik Park, Virginia L. Mihalick, Salvatore Carbone, Matthew S. Halquist, Adam C. Pearcy
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 5, p e0247357 (2021)
PLoS ONE, Vol 16, Iss 5, p e0247357 (2021)
Background Endogenous serine protease inhibitors are associated with anti-inflammatory and pro-survival signaling mediated via Low-density lipoprotein receptor-related protein 1 (LRP1) signaling. SP16 is a short polypeptide that mimics the LRP1 bindi
Publikováno v:
Life Sciences. 299:120557
Monocyte chemokine receptor 2 (CCR2) and phosphorylated extra-cellular regulated kinase 12 (ERK1/2) impact macrophage differentiation and progression of atherosclerosis. Whereas aerobic exercise favorably modulates the immune system and reduces ather
Autor:
Alessandra Vecchié, Edoardo Bressi, Benjamin W. Van Tassell, Salvatore Carbone, George F. Wohlford, Antonio Abbate, Amr Marawan, Dinesh Kadariya, Juan Guido Chiabrando, Hayley Billingsley, Megan Dell, Ai-Chen Ho, Virginia L. Mihalick, Jeremy Turlington, Cory R. Trankle, Roshanak Markley, Aldo Bonaventura, Justin M. Canada, Georgia K. Thomas
Publikováno v:
Journal of Cardiovascular Pharmacology
Supplemental Digital Content is Available in the Text.
The NLRP3 inflammasome has been implicated in the development and progression of heart failure. The aim of this study was to determine the safety of an oral inhibitor of the NLRP3 inflammaso
The NLRP3 inflammasome has been implicated in the development and progression of heart failure. The aim of this study was to determine the safety of an oral inhibitor of the NLRP3 inflammaso
Autor:
Justin M. Canada, Megan Dell, Horacio Medina de Chazal, Krishnasree Rao, Dinesh Kadariya, Salvatore Carbone, Linda Hart, Hayley Billingsley, Edoardo Bressi, Cory R. Trankle, Benjamin W. Van Tassell, Juan Guido Chiabrando, Alessandra Vecchié, Roberta Bogaev, Antonio Abbate, Keyur B. Shah, Roshanak Markley, Virginia L. Mihalick, Dave L. Dixon, Ross Arena, Richard H. Cooke, Francesco S. Celi, Brando Rotelli
Publikováno v:
Diabetes/Metabolism Research and Reviews
Background Canagliflozin reduces hospitalizations for heart failure (HF) in type 2 diabetes mellitus (T2DM). Its effect on cardiorespiratory fitness and cardiac function in patients with established HF with reduced ejection fraction (HFrEF) is unknow